Next Article in Journal
Phase I Clinical Study with the GRPR-Antagonist [99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference?
Previous Article in Journal
Advances in Nasal Biopharmaceutics to Support Product Development and Therapeutic Needs
Previous Article in Special Issue
Peptides as Versatile Regulators in Cancer Immunotherapy: Recent Advances, Challenges, and Future Prospects
 
 
Review

Article Versions Notes

Pharmaceutics 2025, 17(10), 1322; https://doi.org/10.3390/pharmaceutics17101322
Action Date Notes Link
article xml file uploaded 11 October 2025 15:34 CEST Original file -
article xml uploaded. 11 October 2025 15:34 CEST Update https://www.mdpi.com/1999-4923/17/10/1322/xml
article pdf uploaded. 11 October 2025 15:34 CEST Version of Record https://www.mdpi.com/1999-4923/17/10/1322/pdf
article html file updated 11 October 2025 15:35 CEST Original file https://www.mdpi.com/1999-4923/17/10/1322/html
Back to TopTop